Live feed16:01:00·1326dPRReleasevia QuantisnowXencor's IL2-Fc Cytokine, XmAb®564, is Well-tolerated and Selectively Expands Regulatory T Cells in Phase 1a Clinical StudyByQuantisnow·Wall Street's wire, on your screen.XNCR· Xencor Inc.Health Care
